HRP20100401T1 - DERIVATI PIRAZOLO/3,4-d/AZEPINA KAO HISTAMINSKI H3 ANTAGONISTI - Google Patents

DERIVATI PIRAZOLO/3,4-d/AZEPINA KAO HISTAMINSKI H3 ANTAGONISTI Download PDF

Info

Publication number
HRP20100401T1
HRP20100401T1 HR20100401T HRP20100401T HRP20100401T1 HR P20100401 T1 HRP20100401 T1 HR P20100401T1 HR 20100401 T HR20100401 T HR 20100401T HR P20100401 T HRP20100401 T HR P20100401T HR P20100401 T1 HRP20100401 T1 HR P20100401T1
Authority
HR
Croatia
Prior art keywords
alkyl
tetrahydropyrazolo
azepin
compound
phenyl
Prior art date
Application number
HR20100401T
Other languages
English (en)
Croatian (hr)
Inventor
James Bamford Mark
Matthew Wilson David
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HRP20100401T1 publication Critical patent/HRP20100401T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20100401T 2005-07-06 2006-07-04 DERIVATI PIRAZOLO/3,4-d/AZEPINA KAO HISTAMINSKI H3 ANTAGONISTI HRP20100401T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0513886.2A GB0513886D0 (en) 2005-07-06 2005-07-06 Novel compounds
PCT/EP2006/006613 WO2007025596A1 (en) 2005-07-06 2006-07-04 Pyrazolo [3 , 4-d] azepine derivatives as histamine h3 antagonists

Publications (1)

Publication Number Publication Date
HRP20100401T1 true HRP20100401T1 (hr) 2010-09-30

Family

ID=34856781

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100401T HRP20100401T1 (hr) 2005-07-06 2006-07-04 DERIVATI PIRAZOLO/3,4-d/AZEPINA KAO HISTAMINSKI H3 ANTAGONISTI

Country Status (27)

Country Link
US (1) US7888347B2 (OSRAM)
EP (1) EP1899350B1 (OSRAM)
JP (1) JP5145218B2 (OSRAM)
KR (1) KR20080037651A (OSRAM)
CN (1) CN101258154B (OSRAM)
AT (1) ATE467636T1 (OSRAM)
AU (1) AU2006286897A1 (OSRAM)
BR (1) BRPI0612719A2 (OSRAM)
CA (1) CA2614232A1 (OSRAM)
CR (1) CR9622A (OSRAM)
CY (1) CY1110711T1 (OSRAM)
DE (1) DE602006014273D1 (OSRAM)
DK (1) DK1899350T3 (OSRAM)
EA (1) EA013600B1 (OSRAM)
ES (1) ES2345841T3 (OSRAM)
GB (1) GB0513886D0 (OSRAM)
HR (1) HRP20100401T1 (OSRAM)
IL (1) IL188184A0 (OSRAM)
MA (1) MA29623B1 (OSRAM)
MX (1) MX2008000383A (OSRAM)
NO (1) NO20080563L (OSRAM)
PL (1) PL1899350T3 (OSRAM)
PT (1) PT1899350E (OSRAM)
SI (1) SI1899350T1 (OSRAM)
UA (1) UA93047C2 (OSRAM)
WO (1) WO2007025596A1 (OSRAM)
ZA (1) ZA200710798B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
US8829041B2 (en) 2006-06-23 2014-09-09 Abbvie Inc. Cyclopropyl amine derivatives
MX2010002938A (es) 2007-09-24 2010-04-01 Comentis Inc Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
US9186353B2 (en) * 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
WO2012037258A1 (en) 2010-09-16 2012-03-22 Abbott Laboratories Processes for preparing 1,2-substituted cyclopropyl derivatives
CN102952139B (zh) * 2011-08-30 2016-08-10 上海药明康德新药开发有限公司 反式-3a-氟吡咯烷[3,4-C]并环化合物及其制备方法
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
US9910887B2 (en) * 2013-04-25 2018-03-06 Facebook, Inc. Variable search query vertical access
BR112018074231A2 (pt) * 2016-05-25 2019-03-06 Akarna Therapeutics, Ltd. compostos bicíclicos fundidos para o tratamento de doença

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573218B1 (en) * 1998-09-09 2003-06-03 Ishihara Sangyo Kaisha, Ltd. Fused-benzene derivatives useful as herbicides
EP1173438A1 (en) * 1999-04-16 2002-01-23 Novo Nordisk A/S Substituted imidazoles, their preparation and use
JP2001220390A (ja) 2000-02-09 2001-08-14 Yamanouchi Pharmaceut Co Ltd 縮合ピラゾール誘導体
DE60312328T2 (de) * 2002-06-06 2007-11-08 Novo Nordisk A/S Substituierte hexahydropyrrolo(1,2-a)pyrazine, octahydropyrido(1,2-a)pyrazine und decahydropyrazino(1,2-a)azepine
US6770597B2 (en) 2002-07-17 2004-08-03 Ishihara Sangyo Kaisha, Ltd. Benzohydrazide derivatives as herbicides and desiccant compositions containing them
AU2003244649A1 (en) 2002-07-25 2004-02-23 Pharmacia Italia Spa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP1539704A1 (en) * 2002-08-20 2005-06-15 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
GB0224083D0 (en) 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
ATE441417T1 (de) 2002-12-20 2009-09-15 Glaxo Group Ltd Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
AU2004283196B2 (en) * 2003-09-17 2011-08-25 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds
GB0329214D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
GB0405628D0 (en) 2004-03-12 2004-04-21 Glaxo Group Ltd Novel compounds
GB0408083D0 (en) 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
US20070232590A1 (en) 2004-06-18 2007-10-04 Glaxo Group Limited 3-Cylcoalkylbenzazepines as Histamine H3 Antagonists
GB0418267D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Novel compounds
AU2005313550A1 (en) 2004-12-07 2006-06-15 Glaxo Group Limited Indenyl derivatives and use thereof for the treatment of neurological disorders
EP1858900B1 (en) 2005-03-14 2009-01-07 Glaxo Group Limited Fused thiazole derivatives having affinity for the histamine h3 receptor

Also Published As

Publication number Publication date
BRPI0612719A2 (pt) 2010-11-30
CR9622A (es) 2008-04-10
US7888347B2 (en) 2011-02-15
JP5145218B2 (ja) 2013-02-13
UA93047C2 (ru) 2011-01-10
WO2007025596A1 (en) 2007-03-08
ATE467636T1 (de) 2010-05-15
DE602006014273D1 (de) 2010-06-24
JP2009500366A (ja) 2009-01-08
EP1899350B1 (en) 2010-05-12
ZA200710798B (en) 2008-11-26
EA200800264A1 (ru) 2008-06-30
EP1899350A1 (en) 2008-03-19
SI1899350T1 (sl) 2010-09-30
CN101258154A (zh) 2008-09-03
US20080176832A1 (en) 2008-07-24
AU2006286897A1 (en) 2007-03-08
CA2614232A1 (en) 2007-03-08
IL188184A0 (en) 2008-03-20
KR20080037651A (ko) 2008-04-30
EA013600B1 (ru) 2010-06-30
GB0513886D0 (en) 2005-08-10
ES2345841T3 (es) 2010-10-04
CY1110711T1 (el) 2015-06-10
MA29623B1 (fr) 2008-07-01
NO20080563L (no) 2008-02-01
MX2008000383A (es) 2008-03-07
PL1899350T3 (pl) 2010-10-29
DK1899350T3 (da) 2010-09-06
PT1899350E (pt) 2010-07-21
CN101258154B (zh) 2011-01-19

Similar Documents

Publication Publication Date Title
FI3932919T3 (fi) Jak-inhibiittoriyhdiste ja sen käyttö
ES3023040T3 (en) Compounds and methods for the targeted degradation of androgen receptor
RU2011116447A (ru) Модуляторы амилоида бета
JP5128019B1 (ja) オキサジン誘導体および神経障害の処置におけるその使用
RU2011116230A (ru) Пиразолопиридиновые производные как ингибиторы надфн-оксидазы
JP5767214B2 (ja) オキサジン誘導体および神経障害の処置のためのbace阻害剤としてのその使用
HRP20201641T1 (hr) Novi spojevi i njihove farmaceutske kompozicije za liječenje inflamatornih poremećaja
RU2009136299A (ru) Новые производные 3-({1,2,4}триазоло{4,3-а}пиридин-7-ил)бензамида
JP2016523911A5 (OSRAM)
ES2807785T3 (es) Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k
JP2019504009A5 (OSRAM)
TW201619159A (zh) 吡咯并[2,3-d]嘧啶衍生物
CA2515343A1 (en) Antiparasitic terpene alkaloids
JP2013533868A (ja) タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用
RU2009113612A (ru) Ацетамидные производные хиназолинона и изохинолинона
HRP20100401T1 (hr) DERIVATI PIRAZOLO/3,4-d/AZEPINA KAO HISTAMINSKI H3 ANTAGONISTI
JP2009529047A5 (OSRAM)
RU2005121494A (ru) Тиенопиримидиндионы и их применение в модулировании аутоиммунного заболевания
HRP20250088T1 (hr) Derivati piridazin-3(2h)-ona spojeni s azolom
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения
CN105481862B (zh) Flt3激酶的新型抑制剂及其用途
JP2021529815A (ja) 肝再生促進又は肝細胞死の抑制もしくは防止のためのプロテインキナーゼ阻害剤
JP2020537645A (ja) Ehmt2阻害剤としてのアミン置換複素環化合物及びその誘導体
JP2017523223A5 (OSRAM)
RU2009103300A (ru) Производные 2-бензоилимидазопиридинов, их получение и их применение в терапии